252 related articles for article (PubMed ID: 30565905)
1. Lifetime major depression and grey-matter volume.
Ancelin ML; Carrière I; Artero S; Maller J; Meslin C; Ritchie K; Ryan J; Chaudieu I
J Psychiatry Neurosci; 2019 Jan; 44(1):45-53. PubMed ID: 30565905
[TBL] [Abstract][Full Text] [Related]
2. Structural brain alterations in older adults exposed to early-life adversity.
Ancelin ML; Carrière I; Artero S; Maller JJ; Meslin C; Dupuy AM; Ritchie K; Ryan J; Chaudieu I
Psychoneuroendocrinology; 2021 Jul; 129():105272. PubMed ID: 34023732
[TBL] [Abstract][Full Text] [Related]
3. Structural brain changes with lifetime trauma and re-experiencing symptoms is
Ancelin ML; Carriere I; Artero S; Maller JJ; Meslin C; Dupuy AM; Ritchie K; Ryan J; Chaudieu I
Eur J Psychotraumatol; 2020; 11(1):1733247. PubMed ID: 32194924
[No Abstract] [Full Text] [Related]
4. Grey matter volume abnormalities in the first depressive episode of medication-naïve adult individuals: a systematic review of voxel based morphometric studies.
Amidfar M; Quevedo J; Z Réus G; Kim YK
Int J Psychiatry Clin Pract; 2021 Nov; 25(4):407-420. PubMed ID: 33351672
[TBL] [Abstract][Full Text] [Related]
5. The effects of 5-HTTLPR and BDNF Val66Met polymorphisms on neurostructural changes in major depressive disorder.
Han KM; Choi S; Kim A; Kang J; Won E; Tae WS; Kim YK; Lee MS; Ham BJ
Psychiatry Res Neuroimaging; 2018 Mar; 273():25-34. PubMed ID: 29414128
[TBL] [Abstract][Full Text] [Related]
6. The influence of 5-HTTLPR and Val66Met polymorphisms on cortical thickness and volume in limbic and paralimbic regions in depression: a preliminary study.
Jaworska N; MacMaster FP; Foster J; Ramasubbu R
BMC Psychiatry; 2016 Mar; 16():61. PubMed ID: 26976307
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal brain volume changes in major depressive disorder.
Yüksel D; Engelen J; Schuster V; Dietsche B; Konrad C; Jansen A; Dannlowski U; Kircher T; Krug A
J Neural Transm (Vienna); 2018 Oct; 125(10):1433-1447. PubMed ID: 30167933
[TBL] [Abstract][Full Text] [Related]
8. Associations of current and remitted major depressive disorder with brain atrophy: the AGES-Reykjavik Study.
Geerlings MI; Sigurdsson S; Eiriksdottir G; Garcia ME; Harris TB; Sigurdsson T; Gudnason V; Launer LJ
Psychol Med; 2013 Feb; 43(2):317-28. PubMed ID: 22647536
[TBL] [Abstract][Full Text] [Related]
9. Association between serotonin transporter genotype, brain structure and adolescent-onset major depressive disorder: a longitudinal prospective study.
Little K; Olsson CA; Whittle S; Youssef GJ; Byrne ML; Simmons JG; Yücel M; Foley DL; Allen NB
Transl Psychiatry; 2014 Sep; 4(9):e445. PubMed ID: 25226554
[TBL] [Abstract][Full Text] [Related]
10. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression.
Taylor WD; Steffens DC; Payne ME; MacFall JR; Marchuk DA; Svenson IK; Krishnan KR
Arch Gen Psychiatry; 2005 May; 62(5):537-44. PubMed ID: 15867107
[TBL] [Abstract][Full Text] [Related]
11. Larger amygdala volume in first-degree relatives of patients with major depression.
Romanczuk-Seiferth N; Pöhland L; Mohnke S; Garbusow M; Erk S; Haddad L; Grimm O; Tost H; Meyer-Lindenberg A; Walter H; Wüstenberg T; Heinz A
Neuroimage Clin; 2014; 5():62-8. PubMed ID: 25003028
[TBL] [Abstract][Full Text] [Related]
12. Brain grey matter abnormalities in medication-free patients with major depressive disorder: a meta-analysis.
Zhao YJ; Du MY; Huang XQ; Lui S; Chen ZQ; Liu J; Luo Y; Wang XL; Kemp GJ; Gong QY
Psychol Med; 2014 Oct; 44(14):2927-37. PubMed ID: 25065859
[TBL] [Abstract][Full Text] [Related]
13. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder.
Zhao Y; Chen L; Zhang W; Xiao Y; Shah C; Zhu H; Yuan M; Sun H; Yue Q; Jia Z; Zhang W; Kuang W; Gong Q; Lui S
EBioMedicine; 2017 Jul; 21():228-235. PubMed ID: 28633986
[TBL] [Abstract][Full Text] [Related]
14. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
[TBL] [Abstract][Full Text] [Related]
15. Brain structural abnormalities in emotional regulation and sensory processing regions associated with anxious depression.
Peng W; Jia Z; Huang X; Lui S; Kuang W; Sweeney JA; Gong Q
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109676. PubMed ID: 31226395
[TBL] [Abstract][Full Text] [Related]
16. Large-scale evidence for an association between low-grade peripheral inflammation and brain structural alterations in major depression in the BiDirect study.
Opel N; Cearns M; Clark S; Toben C; Grotegerd D; Heindel W; Kugel H; Teuber A; Minnerup H; Berger K; Dannlowski U; Baune BT
J Psychiatry Neurosci; 2019 Nov; 44(6):423-431. PubMed ID: 31304733
[TBL] [Abstract][Full Text] [Related]
17. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
18. White matter abnormalities in major depression: evidence from post-mortem, neuroimaging and genetic studies.
Tham MW; Woon PS; Sum MY; Lee TS; Sim K
J Affect Disord; 2011 Jul; 132(1-2):26-36. PubMed ID: 20889213
[TBL] [Abstract][Full Text] [Related]
19. Specificity of abnormal brain volume in major depressive disorder: a comparison with borderline personality disorder.
Depping MS; Wolf ND; Vasic N; Sambataro F; Thomann PA; Christian Wolf R
J Affect Disord; 2015 Mar; 174():650-7. PubMed ID: 25577159
[TBL] [Abstract][Full Text] [Related]
20. Voxel-based morphometric brain comparison between healthy subjects and major depressive disorder patients in Japanese with the s/s genotype of 5-HTTLPR.
Igata N; Kakeda S; Watanabe K; Ide S; Kishi T; Abe O; Igata R; Katsuki A; Iwata N; Yoshimura R; Korogi Y
Sci Rep; 2017 Jun; 7(1):3931. PubMed ID: 28638109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
